Figure 2. Survival analysis according to the expression of FAM83H, SCRIB, and β-catenin in early gastric cancers and advanced gastric cancers. Kaplan-Meier survival curves for overall survival and relapse-free survival in 50 early gastric cancers (A) and 150 advanced gastric cancers (B).